motor neurone disease association
motor neurone disease association Company Information
Company Number
02007023
Website
http://mndassociation.orgRegistered Address
francis crick house, summerhouse road, northampton, NN3 6BF
Industry
Other human health activities
Telephone
01604250505
Next Accounts Due
September 2025
Group Structure
View All
Shareholders
-0%
motor neurone disease association Estimated Valuation
Pomanda estimates the enterprise value of MOTOR NEURONE DISEASE ASSOCIATION at £39.9m based on a Turnover of £37.9m and 1.05x industry multiple (adjusted for size and gross margin).
motor neurone disease association Estimated Valuation
Pomanda estimates the enterprise value of MOTOR NEURONE DISEASE ASSOCIATION at £119.6m based on an EBITDA of £14.1m and a 8.47x industry multiple (adjusted for size and gross margin).
motor neurone disease association Estimated Valuation
Pomanda estimates the enterprise value of MOTOR NEURONE DISEASE ASSOCIATION at £16m based on Net Assets of £44.3m and 0.36x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Motor Neurone Disease Association Overview
Motor Neurone Disease Association is a live company located in northampton, NN3 6BF with a Companies House number of 02007023. It operates in the other human health activities sector, SIC Code 86900. Founded in April 1986, it's largest shareholder is unknown. Motor Neurone Disease Association is a mature, large sized company, Pomanda has estimated its turnover at £37.9m with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Motor Neurone Disease Association Health Check
Pomanda's financial health check has awarded Motor Neurone Disease Association a 5 rating. We use a traffic light system to show it exceeds the industry average on 7 measures and has 3 areas for improvement. Company Health Check FAQs
7 Strong
1 Regular
3 Weak
Size
annual sales of £37.9m, make it larger than the average company (£742k)
£37.9m - Motor Neurone Disease Association
£742k - Industry AVG
Growth
3 year (CAGR) sales growth of 24%, show it is growing at a faster rate (6.1%)
24% - Motor Neurone Disease Association
6.1% - Industry AVG
Production
with a gross margin of 35.6%, this company has a comparable cost of product (35.6%)
35.6% - Motor Neurone Disease Association
35.6% - Industry AVG
Profitability
an operating margin of 36.6% make it more profitable than the average company (5.4%)
36.6% - Motor Neurone Disease Association
5.4% - Industry AVG
Employees
with 215 employees, this is above the industry average (18)
215 - Motor Neurone Disease Association
18 - Industry AVG
Pay Structure
on an average salary of £42.9k, the company has a higher pay structure (£25.9k)
£42.9k - Motor Neurone Disease Association
£25.9k - Industry AVG
Efficiency
resulting in sales per employee of £176.4k, this is more efficient (£48.2k)
£176.4k - Motor Neurone Disease Association
£48.2k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Motor Neurone Disease Association
- - Industry AVG
Creditor Days
its suppliers are paid after 20 days, this is slower than average (17 days)
20 days - Motor Neurone Disease Association
17 days - Industry AVG
Stock Days
it holds stock equivalent to 0 days, this is less than average (13 days)
0 days - Motor Neurone Disease Association
13 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 87 weeks, this is less cash available to meet short term requirements (115 weeks)
87 weeks - Motor Neurone Disease Association
115 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 31.9%, this is a higher level of debt than the average (24.6%)
31.9% - Motor Neurone Disease Association
24.6% - Industry AVG
MOTOR NEURONE DISEASE ASSOCIATION financials
Motor Neurone Disease Association's latest turnover from December 2023 is £37.9 million and the company has net assets of £44.3 million. According to their latest financial statements, Motor Neurone Disease Association has 215 employees and maintains cash reserves of £22.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 37,922,000 | 30,045,000 | 28,943,000 | 19,911,000 | 18,633,000 | 18,744,000 | 18,955,000 | 17,391,000 | 16,683,000 | 25,278,000 | 16,756,000 | 13,270,000 | 12,715,000 | 13,043,986 | 11,690,093 |
| Other Income Or Grants | |||||||||||||||
| Cost Of Sales | |||||||||||||||
| Gross Profit | |||||||||||||||
| Admin Expenses | |||||||||||||||
| Operating Profit | |||||||||||||||
| Interest Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pre-Tax Profit | 11,137,000 | 7,249,000 | 10,842,000 | 4,368,000 | 503,000 | 80,000 | -194,000 | 211,000 | -7,686,000 | 8,934,000 | 3,245,000 | 363,000 | -2,021,000 | -2,038,751 | -2,054,324 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Tax | 11,137,000 | 7,249,000 | 10,842,000 | 4,368,000 | 503,000 | 80,000 | -194,000 | 211,000 | -7,686,000 | 8,934,000 | 3,245,000 | 363,000 | -2,021,000 | -2,038,751 | -2,054,324 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Profit | 11,137,000 | 7,249,000 | 10,842,000 | 4,368,000 | 503,000 | 80,000 | -194,000 | 211,000 | -7,686,000 | 8,934,000 | 3,245,000 | 363,000 | -2,021,000 | -2,038,751 | -2,054,324 |
| Employee Costs | 9,229,000 | 8,064,000 | 7,044,000 | 7,036,000 | 7,149,000 | 7,206,000 | 7,021,000 | 6,268,000 | 6,217,000 | 5,625,000 | 5,034,000 | 4,926,000 | 5,457,000 | 5,389,419 | 4,950,169 |
| Number Of Employees | 215 | 204 | 180 | 178 | 186 | 195 | 190 | 189 | 170 | 158 | 140 | 136 | 149 | 145 | 134 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 304,000 | 444,000 | 581,000 | 835,000 | 718,000 | 294,000 | 266,000 | 321,000 | 414,000 | 198,000 | 215,000 | 169,000 | 326,000 | 523,802 | 554,719 |
| Intangible Assets | 0 | 0 | 0 | 0 | 2,000 | 16,000 | 26,000 | 38,000 | 29,000 | 12,000 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 5,208,000 | 5,000,000 | 0 | 0 | 0 | 0 | 2,282,000 | 2,271,000 | 4,093,000 | 270,000 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 5,512,000 | 5,444,000 | 581,000 | 835,000 | 720,000 | 310,000 | 2,574,000 | 2,630,000 | 4,536,000 | 480,000 | 215,000 | 169,000 | 326,000 | 523,802 | 554,719 |
| Stock & work in progress | 23,000 | 20,000 | 22,000 | 31,000 | 29,000 | 33,000 | 31,000 | 28,000 | 31,000 | 16,000 | 11,000 | 13,000 | 17,000 | 10,298 | 5,202 |
| Trade Debtors | 0 | 0 | 0 | 0 | 4,769,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2,943,328 | 3,159,800 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 10,136,000 | 9,569,000 | 7,900,000 | 5,544,000 | 0 | 4,780,000 | 4,371,000 | 5,462,000 | 3,978,000 | 2,776,000 | 4,089,000 | 3,440,000 | 3,347,000 | 348,018 | 613,934 |
| Cash | 22,625,000 | 16,870,000 | 15,434,000 | 12,619,000 | 10,402,000 | 8,366,000 | 7,976,000 | 5,604,000 | 7,861,000 | 5,410,000 | 10,218,000 | 7,366,000 | 6,892,000 | 7,020,039 | 7,815,003 |
| misc current assets | 26,805,000 | 19,326,000 | 17,238,000 | 9,200,000 | 9,365,000 | 11,126,000 | 10,528,000 | 12,065,000 | 8,649,000 | 16,000,000 | 0 | 0 | 24,000 | 1,592,183 | 1,519,905 |
| total current assets | 59,589,000 | 45,785,000 | 40,594,000 | 27,394,000 | 24,565,000 | 24,305,000 | 22,906,000 | 23,159,000 | 20,519,000 | 24,202,000 | 14,318,000 | 10,819,000 | 10,280,000 | 11,913,866 | 13,113,844 |
| total assets | 65,101,000 | 51,229,000 | 41,175,000 | 28,229,000 | 25,285,000 | 24,615,000 | 25,480,000 | 25,789,000 | 25,055,000 | 24,682,000 | 14,533,000 | 10,988,000 | 10,606,000 | 12,437,668 | 13,668,563 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,359,000 | 615,000 | 995,000 | 1,022,000 | 708,000 | 563,000 | 505,000 | 827,000 | 656,000 | 193,000 | 219,000 | 215,000 | 620,000 | 658,993 | 624,297 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 28,000 | 38,000 | 38,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 12,135,000 | 11,936,000 | 8,799,000 | 8,971,000 | 10,441,000 | 10,529,000 | 10,006,000 | 7,572,000 | 7,132,000 | 5,270,000 | 4,383,000 | 5,118,000 | 4,610,000 | 4,395,944 | 3,613,554 |
| total current liabilities | 13,494,000 | 12,551,000 | 9,794,000 | 9,993,000 | 11,149,000 | 11,092,000 | 10,539,000 | 8,437,000 | 7,826,000 | 5,463,000 | 4,602,000 | 5,333,000 | 5,230,000 | 5,054,937 | 4,237,851 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 28,000 | 61,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 7,274,000 | 5,464,000 | 5,407,000 | 3,104,000 | 3,372,000 | 3,262,000 | 4,740,000 | 6,945,000 | 7,027,000 | 1,392,000 | 1,031,000 | 0 | 86,000 | 169,156 | 250,664 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 7,274,000 | 5,464,000 | 5,407,000 | 3,104,000 | 3,372,000 | 3,262,000 | 4,740,000 | 6,973,000 | 7,088,000 | 1,392,000 | 1,031,000 | 0 | 86,000 | 169,156 | 250,664 |
| total liabilities | 20,768,000 | 18,015,000 | 15,201,000 | 13,097,000 | 14,521,000 | 14,354,000 | 15,279,000 | 15,410,000 | 14,914,000 | 6,855,000 | 5,633,000 | 5,333,000 | 5,316,000 | 5,224,093 | 4,488,515 |
| net assets | 44,333,000 | 33,214,000 | 25,974,000 | 15,132,000 | 10,764,000 | 10,261,000 | 10,201,000 | 10,379,000 | 10,141,000 | 17,827,000 | 8,900,000 | 5,655,000 | 5,290,000 | 7,213,575 | 9,180,048 |
| total shareholders funds | 44,333,000 | 33,214,000 | 25,974,000 | 15,132,000 | 10,764,000 | 10,261,000 | 10,201,000 | 10,379,000 | 10,141,000 | 17,827,000 | 8,900,000 | 5,655,000 | 5,290,000 | 7,213,575 | 9,180,048 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Jan 2016 | Jan 2015 | Jan 2014 | Jan 2013 | Jan 2012 | Jan 2011 | Jan 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||
| Operating Profit | |||||||||||||||
| Depreciation | 266,000 | 263,000 | 326,000 | 345,000 | 6,000 | 9,000 | 12,000 | 1,798,000 | 161,000 | 121,000 | 144,000 | 224,000 | 321,000 | 339,777 | 268,819 |
| Amortisation | 0 | 0 | 0 | 2,000 | 0 | 0 | 0 | 0 | 5,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock | 3,000 | -2,000 | -9,000 | 2,000 | -4,000 | 2,000 | 3,000 | 12,000 | 15,000 | 5,000 | -2,000 | -4,000 | 6,702 | 5,096 | 5,202 |
| Debtors | 567,000 | 1,669,000 | 2,356,000 | 775,000 | -11,000 | 409,000 | -1,091,000 | 2,686,000 | 1,202,000 | -1,313,000 | 649,000 | 93,000 | 55,654 | -482,388 | 3,773,734 |
| Creditors | 744,000 | -380,000 | -27,000 | 314,000 | 145,000 | 58,000 | -322,000 | 634,000 | 463,000 | -26,000 | 4,000 | -405,000 | -38,993 | 34,696 | 624,297 |
| Accruals and Deferred Income | 199,000 | 3,137,000 | -172,000 | -1,470,000 | -88,000 | 523,000 | 2,434,000 | 2,302,000 | 1,862,000 | 887,000 | -735,000 | 508,000 | 214,056 | 782,390 | 3,613,554 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||||||
| Investing Activities | |||||||||||||||
| capital expenditure | 0 | 0 | 0 | 0 | 0 | 2,021,000 | 52,000 | 1,830,000 | -407,000 | -393,000 | -193,000 | -68,000 | -123,000 | -308,859 | -426,103 |
| Change in Investments | 208,000 | 5,000,000 | 0 | 0 | 0 | -2,282,000 | 11,000 | 2,001,000 | 3,823,000 | 270,000 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | -208,000 | -5,000,000 | 0 | 0 | 0 | 4,303,000 | 41,000 | -171,000 | -4,230,000 | -663,000 | -193,000 | -68,000 | -123,000 | -308,859 | -426,103 |
| Financing Activities | |||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | -28,000 | -38,000 | 66,000 | 99,000 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 1,810,000 | 57,000 | 2,303,000 | -268,000 | 110,000 | -1,478,000 | -2,205,000 | 5,553,000 | 5,635,000 | 361,000 | 1,031,000 | -86,000 | -83,156 | -81,508 | 250,664 |
| share issue | |||||||||||||||
| interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from financing | 1,792,000 | 48,000 | 2,303,000 | -268,000 | 110,000 | -1,526,000 | -2,227,000 | -2,040,000 | 5,734,000 | 354,000 | 1,031,000 | -84,000 | 14,269 | -9,230 | 11,485,036 |
| cash and cash equivalents | |||||||||||||||
| cash | 5,755,000 | 1,436,000 | 2,815,000 | 2,217,000 | 2,036,000 | 390,000 | 2,372,000 | 194,000 | 2,451,000 | -4,808,000 | 2,852,000 | 474,000 | -128,039 | -794,964 | 7,815,003 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 5,755,000 | 1,436,000 | 2,815,000 | 2,217,000 | 2,036,000 | 390,000 | 2,372,000 | 194,000 | 2,451,000 | -4,808,000 | 2,852,000 | 474,000 | -128,039 | -794,964 | 7,815,003 |
motor neurone disease association Credit Report and Business Information
Motor Neurone Disease Association Competitor Analysis
Perform a competitor analysis for motor neurone disease association by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other large companies, companies in NN3 area or any other competitors across 12 key performance metrics.
motor neurone disease association Ownership
MOTOR NEURONE DISEASE ASSOCIATION group structure
Motor Neurone Disease Association has 1 subsidiary company.
Ultimate parent company
MOTOR NEURONE DISEASE ASSOCIATION
02007023
1 subsidiary
motor neurone disease association directors
Motor Neurone Disease Association currently has 13 directors. The longest serving directors include Mrs Catherine Knights (Jul 2019) and Dr Shaun McGee (May 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Catherine Knights | England | 63 years | Jul 2019 | - | Director |
| Dr Shaun McGee | England | 65 years | May 2020 | - | Director |
| Ms Elizabeth Ellis | England | 78 years | Jul 2021 | - | Director |
| Mr James Marshall | 64 years | Jul 2021 | - | Director | |
| Dr Usman Khan | 61 years | Jul 2021 | - | Director | |
| Ms Kirrie Todd | England | 55 years | May 2022 | - | Director |
| Mr Simon Croxford | England | 53 years | Jun 2022 | - | Director |
| Mr Ian Lev | England | 66 years | Jun 2022 | - | Director |
| Dr John Ealing | England | 54 years | Feb 2023 | - | Director |
| Ms Hazel Carter | England | 67 years | Jul 2023 | - | Director |
P&L
December 2023turnover
37.9m
+26%
operating profit
13.9m
0%
gross margin
35.6%
+2.11%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
44.3m
+0.33%
total assets
65.1m
+0.27%
cash
22.6m
+0.34%
net assets
Total assets minus all liabilities
Similar Companies
motor neurone disease association company details
company number
02007023
Type
Private Ltd By Guarantee w/o Share Cap
industry
86900 - Other human health activities
incorporation date
April 1986
age
38
incorporated
UK
accounts
Group
ultimate parent company
previous names
N/A
last accounts submitted
December 2023
address
francis crick house, summerhouse road, northampton, NN3 6BF
accountant
-
auditor
HAYSMACINTYRE LLP
motor neurone disease association Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to motor neurone disease association.
motor neurone disease association Companies House Filings - See Documents
| date | description | view/download |
|---|
